Abstract:As a new CRISPR/Cas-derived genome engineering technology, base editing combines the target specificity of CRISPR/Cas and the catalytic activity of nucleobase deaminase to install point mutations at target loci without generating DSBs, requiring exogenous template, or depending on homologous recombination. Recently, researchers have developed a variety of base editing tools in the important industrial strain Corynebacterium glutamicum, and achieved simultaneous editing of two and three genes. However, the multiplex base editing based on CRISPR/Cas9 is still limited by the complexity of multiple sgRNAs, interference of repeated sequence and difficulty of target loci replacement. In this study, multiplex base editing in C. glutamicum was optimized by the following strategies. Firstly, the multiple sgRNA expression cassettes based on individual promoters/terminators was optimized. The target loci can be introduced and replaced rapidly by using a template plasmid and Golden Gate method, which also avoids the interference of repeated sequence. Although the multiple sgRNAs structure is still complicated, the editing efficiency of this strategy is the highest. Then, the multiple gRNA expression cassettes based on Type Ⅱ CRISPR crRNA arrays and tRNA processing were developed. The two strategies only require one single promoter and terminator, and greatly simplify the structure of the expression cassette. Although the editing efficiency has decreased, both methods are still applicable. Taken together, this study provides a powerful addition to the genome editing toolbox of C. glutamicum and facilitates genetic modification of this strain.

Engineered minimal type I CRISPR-Cas system for transcriptional activation and base editing in human cells

[Optimization of CRISPR/Cas9-based multiplex base editing in Corynebacterium glutamicum].

Structure and genome editing of type I-B CRISPR-Cas

A transferrable and integrative type I-F Cascade for heterologous genome editing and transcription modulation

Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing

Programmed genome editing by a miniature CRISPR-Cas12f nuclease

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing

Rationally designed Campylobacter jejuni Cas9 enables efficient gene activation and base editing

Engineered CRISPRa System for Precise and Multiplex Gene Regulation Using a Hybrid Dcas12a Variant and Hairpin-Spacer Crrnas.

Miniature CRISPR-Cas12 Systems: Mechanisms, Engineering, and Genome Editing Applications

Advances in miniature CRISPR-Cas proteins and their applications in gene editing

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

CRISPR beyond: harnessing compact RNA-guided endonucleases for enhanced genome editing

Genome editing in mammalian cells using the CRISPR type I-D nuclease

DNA targeting by compact Cas9d and its resurrected ancestor

An engineered Cas12i nuclease that is an efficient genome editing tool in animals and plants

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family